Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Gains from Sales and Divestitures: 2011-2013

Historic Gains from Sales and Divestitures for Lifecore Biomedical (LFCR) over the last 3 years, with May 2013 value amounting to -$217,000.

  • Lifecore Biomedical's Gains from Sales and Divestitures was N/A to -$37,000 in Q2 2013 from the same period last year, while for May 2011 it was $26,000, marking a year-over-year change of. This contributed to the annual value of -$217,000 for FY2013, which is 1708.33% down from last year.
  • As of FY2013, Lifecore Biomedical's Gains from Sales and Divestitures stood at -$217,000, which was down 1,708.33% from -$12,000 recorded in FY2012.
  • Lifecore Biomedical's 5-year Gains from Sales and Divestitures high stood at $26,000 for FY2011, and its period low was -$217,000 during FY2013.
  • In the last 3 years, Lifecore Biomedical's Gains from Sales and Divestitures had a median value of -$12,000 in 2012 and averaged -$67,667.
  • Data for Lifecore Biomedical's Gains from Sales and Divestitures shows a maximum YoY slumped of 1,708.33% (in 2013) over the last 5 years.
  • Over the past 3 years, Lifecore Biomedical's Gains from Sales and Divestitures (Yearly) stood at $26,000 in 2011, then plummeted by 146.15% to -$12,000 in 2012, then plummeted by 1,708.33% to -$217,000 in 2013.